πŸ‡ΊπŸ‡Έ FDA
Patent

US 8703920

Fully human antibodies against N-cadherin

granted A61KA61K2039/505A61K39/3955

Quick answer

US patent 8703920 (Fully human antibodies against N-cadherin) held by The Regents of the University of California expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K2039/505, A61K39/3955, A61P, A61P35/00